129 related articles for article (PubMed ID: 9512255)
21. Benefits of vitamin E supplementation to Norplant users--in vitro and in vivo studies.
Subakir SB; Setiadi E; Affandi B; Pringgoutomo S; Freisleben HJ
Toxicology; 2000 Aug; 148(2-3):173-8. PubMed ID: 10962136
[TBL] [Abstract][Full Text] [Related]
22. Management of irregular uterine bleeding and spotting associated with Norplant.
Archer DF; Philput CA; Weber ME
Hum Reprod; 1996 Oct; 11 Suppl 2():24-30. PubMed ID: 8982742
[TBL] [Abstract][Full Text] [Related]
23. Angiogenic effects of norplant contraception on endometrial histology and uterine bleeding.
Pritts EA; Ryan IP; Mueller MD; Lebovic DI; Shifren JL; Zaloudek CJ; Korn AP; Darney PD; Taylor RN
J Clin Endocrinol Metab; 2005 Apr; 90(4):2142-7. PubMed ID: 15623808
[TBL] [Abstract][Full Text] [Related]
24. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel.
Rogers PA; Au CL; Affandi B
Hum Reprod; 1993 Sep; 8(9):1396-404. PubMed ID: 8253925
[TBL] [Abstract][Full Text] [Related]
25. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
Lau TM; Witjaksono J; Affandi B; Rogers PA
Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
[TBL] [Abstract][Full Text] [Related]
26. Vaginal bleeding disturbances and implantable contraceptives.
Hickey M; d'Arcangues C
Contraception; 2002 Jan; 65(1):75-84. PubMed ID: 11861057
[TBL] [Abstract][Full Text] [Related]
27. Progesterone receptor in Norplant endometrium.
Lau TM; Witjaksono J; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():90-4. PubMed ID: 8982750
[TBL] [Abstract][Full Text] [Related]
28. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
Sivin I
Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives.
Vincent AJ; Zhang J; Ostor A; Rogers PA; Affandi B; Kovacs G; Salamonsen LA
Hum Reprod; 2000 Jan; 15(1):123-30. PubMed ID: 10611200
[TBL] [Abstract][Full Text] [Related]
30. A review of the endometrial changes in Norplant users.
Wan LS
Ann N Y Acad Sci; 1997 Sep; 828():108-10. PubMed ID: 9329828
[TBL] [Abstract][Full Text] [Related]
31. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
Wonodirekso S; Hadisaputra W; Affandi B; Siregar B; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():144-9. PubMed ID: 8982756
[TBL] [Abstract][Full Text] [Related]
32. [The changes of sex steroid receptors and morphology in Norplant treated endometrium].
Wang G; Zheng S; Fan Z
Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):493-7. PubMed ID: 10806752
[TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
[TBL] [Abstract][Full Text] [Related]
34. [Vaginal bleeding patterns and the regularity in use of Norplant].
Meng F; Fan H; Han L
Zhonghua Yi Xue Za Zhi; 1996 May; 76(5):331-4. PubMed ID: 9206192
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
36. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
37. Perivascular smooth muscle alpha-actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding.
Rogers PA; Plunkett D; Affandi B
Hum Reprod; 2000 Aug; 15 Suppl 3():78-84. PubMed ID: 11041224
[TBL] [Abstract][Full Text] [Related]
38. [Study on relationship between endometrium laminin expression and irregular uterine bleeding in Norplant users].
Shi X; Han X; Weng J
Zhonghua Fu Chan Ke Za Zhi; 2000 Mar; 35(3):169-71. PubMed ID: 11775898
[TBL] [Abstract][Full Text] [Related]
39. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon.
Affandi B
Contraception; 1998 Dec; 58(6 Suppl):99S-107S. PubMed ID: 10095980
[TBL] [Abstract][Full Text] [Related]
40. Prolonged endometrial stimulation associated with oestradiol implants.
Gangar KF; Fraser D; Whitehead MI; Cust MP
BMJ; 1990 Feb; 300(6722):436-8. PubMed ID: 2107895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
